About Satyakiran Life Sciences Private Limited
Data last updated:
Satyakiran Life Sciences Private Limited was a private limited company based in Delhi, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the hospital and clinical services segment of the healthcare sector. It was incorporated on 07 March 2005.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U85110DL2005PTC133667.
The company had an authorised share capital of ₹50 Lakh and a paid-up capital of ₹45 Lakh. It was led by directors Sahil Aggarwal and Rakesh Aggarwal.
Its last annual general meeting (AGM) was held on 26 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office was at D – 11 Second Floor Prashant Vihar Rohini, Delhi, India – 110085.
As per the financials filed for FY 2023, the company reported a revenue of ₹2.21 Lakh, a growth of 115% compared to the previous year. For the same year it recorded a net profit of ₹1.05 Lakh (net margin 47.6%) and EBITDA of -₹97,263 (EBITDA margin -44.1%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 2% over five years.
The last known website on record is satyakiran.com.
Company details
Contact details
Satyakiran Life Sciences Private Limited's registered office is in Delhi, Delhi. Its website is satyakiran.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressD – 11 Second Floor Prashant Vihar Rohini, Delhi, India – 110085
- IndustryHealthcare, Hospitals
To see the full contact details of Satyakiran Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Satyakiran Life Sciences Private Limited
FY 2025 filings availableSatyakiran Life Sciences Private Limited reported revenue of ₹2.21 Lakh (up 115% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 115% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹2.21 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹97,263 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.05 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -44.1% | ||||
| Net Profit Margin | 47.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Satyakiran Life Sciences Private Limited, buy the company report.
Board of directors of Satyakiran Life Sciences Private Limited
Satyakiran Life Sciences has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sahil Aggarwal Also directs: Satyakiran Life Sciences LLP, RSR Education LLP, Gateway International School LLP and 5 more | Director | 06 Feb 2017 | 9 Years 9 Months | As last reported |
| Rakesh Aggarwal Also directs: Satyakiran Life Sciences LLP, RSR Education LLP, Gateway International School LLP and 5 more | Director | 14 Dec 2020 | 5 Years 11 Months | As last reported |
Auditor
Satyakiran Life Sciences Private Limited is audited by Mittal & Mittal Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Mittal & Mittal Associates | FY 2023 | 014511N |
Shareholding
The shareholding of Satyakiran Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Satyakiran Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Satyakiran Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Satyakiran Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Satyakiran Life Sciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Satyakiran Life Sciences Private Limited has 7 board changes on record since 2017: 2 appointments and 5 cessations. The latest: Mahesh Gupta ceased to be Director on 15 Dec 2020.
Frequently asked questions
Satyakiran Life Sciences has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Satyakiran Life Sciences was a private limited company based in Delhi, India. The company worked in hospitals, within the healthcare industry. It was incorporated on 07 March 2005 and is registered under CIN U85110DL2005PTC133667. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Satyakiran Life Sciences is U85110DL2005PTC133667. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Satyakiran Life Sciences had 2 directors:
- Sahil Aggarwal - Director
- Rakesh Aggarwal - Director
Satyakiran Life Sciences was incorporated on 07 March 2005. It is registered with the Registrar of Companies, Delhi.
Satyakiran Life Sciences can be reached through the website satyakiran.com. Its registered office is in Delhi, India.
The registered office of Satyakiran Life Sciences is at D – 11 Second Floor Prashant Vihar Rohini, Delhi, India – 110085.
The latest financial statements of Satyakiran Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 July 2025. Year-wise statements from 2015 are in the company report.
Satyakiran Life Sciences operated in the healthcare industry, in the hospitals segment.
Mahesh Gupta ceased to be Director on 15 Dec 2020. Rakesh Aggarwal was appointed as Director on 14 Dec 2020. Sahil Aggarwal ceased to be Additional Director on 29 Sep 2017. Satyakiran Life Sciences has 7 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
